Terodiline: Difference between revisions
No edit summary |
m (Protected "Terodiline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Latest revision as of 17:14, 20 August 2015
WikiDoc Resources for Terodiline |
Articles |
---|
Most recent articles on Terodiline |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Terodiline at Clinical Trials.gov Clinical Trials on Terodiline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Terodiline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Terodiline Discussion groups on Terodiline Patient Handouts on Terodiline Directions to Hospitals Treating Terodiline Risk calculators and risk factors for Terodiline
|
Healthcare Provider Resources |
Causes & Risk Factors for Terodiline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Terodiline is a drug used in urology as an antispasmodic.
It relaxes the smooth muscle and used to reduce bladder tone in treatment of urinary frequency and incontinence. Muscle relaxation caused by terodiline, is probably due to its anticholinergic and calcium antagonist activity.
However, it also blocks IKr (Kv11.1) channels (see hERG gene) so can pose a risk for torsades de pointes. This cardiotoxicity is concentration dependent.